Share Name Share Symbol Market Type Share ISIN Share Description
Northw.Bio Di LSE:NWBT London Ordinary Share US66737P5017 COM SHS USD0.001 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 15.00p 0.00p 0.00p - - - 0.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology - - - - 4.84

Northw.Bio Di Share Discussion Threads

Showing 1 to 2 of 25 messages
Chat Pages: 1
DateSubjectAuthorDiscuss
10/10/2007
13:02
NWBT have developed the world's first therapeutic vaccine for Brain Cancer, DCVax(R)-Brain, which is commercially available to patients in Switzerland. Clinical trial data has shown that the vaccine delays disease recurrence by nearly 3-fold, from 6.9 months to 18.1 months for newly diagnosed patients, and also extends these patients' survival from 14.6 months to more than 33 months. http://www.advfn.com/p.php?pid=nmona&cb=1192020865&article=21342672&symbol=L%5ENWBT
kozel
10/10/2007
12:16
Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercialising immunotherapy products that generate and enhance immune system responses to treat cancer. Website: http://www.nwbio.com/
kozel
Chat Pages: 1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20161206 08:15:10